Amgen (AMGN) News
NASDAQ: AMGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
414.87+7.43 (+1.82%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
AMGN news summary
We found 41 recent headlines mentioning Amgen (AMGN): 11 in the past week and 31 in the past 30 days, most often from Nasdaq, Seeking Alpha. For price context, AMGN is up 1.82% at $414.87. The most recent story, "Amgen (AMGN) Laps the Stock Market: Here's Why", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Amgen headlines
- Amgen (AMGN) Laps the Stock Market: Here's WhyIn the closing of the recent trading day, Amgen (AMGN) stood at $414.87, denoting a +1.82% move from the preceding trading day.Nasdaq
- A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That HappensKey PointsAbbVie has a diversified portfolio of drugs and a deep pipeline that could help it overcome patent cliffs.NasdaqABBV, AMGN
- J&J Stock Ahead of Q3 Earnings: Should You Buy, Sell or Hold?JNJ heads into Q3 earnings with strong drug sales and new launches, but Stelara biosimilar competition and MedTech challenges could weigh on growth.NasdaqJNJ, AMGN, TEVA
- Dow Movers: BA, HONIVIn early trading on Thursday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7.5%. Year to date, Honeywell…NasdaqBA, AMGN, CVX
- Stocks Settle Lower on Higher Bond YieldsThe S&P 500 Index ($SPX ) (SPY ) closed down by -0.22% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.66%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down…NasdaqMSTR, DE, RARE, ADI
- Amgen (AMGN) Advances While Market Declines: Some Information for InvestorsIn the closing of the recent trading day, Amgen (AMGN) stood at $413.08, denoting a +2.6% move from the preceding trading day.Nasdaq
- Where Will Eli Lilly Stock Be in 5 Years? Follow the Pipeline Beyond ZepboundKey PointsEli Lilly has attractive pipeline candidates within its core therapeutic area.NasdaqLLY, NVO, AMGN
- Dow Movers: CAT, HONIVIn early trading on Wednesday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7.5%. Year to date, Honeywell…NasdaqCAT, GS, AMGN
- Noteworthy ETF Inflows: QQQM, TXN, AMGN, MRVLLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco NASDAQ 100 ETF (Symbol: QQQM) where we have detected an…NasdaqQQQM, TXN, AMGN, MRVL
- Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItAmgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.Nasdaq
- Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?Key PointsAmgen offers a diversified portfolio of established therapies across oncology and inflammation supported by robust cash flow.NasdaqAMGN, VRTX
- AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilotSeeking AlphaAMGN, ABBV, PFE
- J&J's Innovative Medicine Segment in Q3: Key Growth Drivers to WatchJNJ's Innovative Medicine segment is poised for another quarter of growth, with oncology and new launches helping offset Stelara's biosimilar-driven decline.NasdaqJNJ, AZN, AMGN, ABBV
- Amgen (AMGN) Stock Dips While Market Gains: Key FactsAmgen (AMGN) closed at $407.27 in the latest trading session, marking a -3.38% move from the prior day.Nasdaq
- Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to WinLLY and Novo face off at EASD as new data fuels the GLP-1 market, while ETFs offer diversified exposure to weight loss drug growth.NasdaqREGN, PFE, NVO, LLY
- Pliant Therapeutics Names David Raben As CMO To Lead PLN-101095 Development(RTTNews) - Pliant Therapeutics (PLRX), a clinical-stage biotechnology company focused on developing integrin-based therapeutics, announced the appointment of David Raben, M.D., as Chief Medical…NasdaqAMGN, BCAX, PLRX
- Invesco NASDAQ 100 ETF Experiences Big InflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco NASDAQ 100 ETF (Symbol: QQQM) where we have detected an…NasdaqQQQM, TXN, MRVL, AMGN
- Take the Zacks Approach to Beat the Markets: Bloom Energy, Microsoft & Amgen in FocusMicrosoft, Bloom Energy and Amgen highlight Zacks' latest market moves, with strong gains across Focus List, recommendation and dividend portfolios.NasdaqMSFT, ACN, KO, AMGN
- 2 Healthcare Stocks That Just Delivered Great News for InvestorsKey PointsVertex Pharmaceuticals and Amgen recently posted strong clinical trial results for promising candidates.NasdaqVRTX, AMGN
- Amgen (AMGN) Rises Higher Than Market: Key FactsIn the latest trading session, Amgen (AMGN) closed at $414.61, marking a +2.11% move from the previous day.Nasdaq
- Stocks Settle Mixed as Chipmakers Climb and Financial Stocks FallThe S&P 500 Index ($SPX ) (SPY ) closed unchanged on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.82%.…NasdaqMPC, SNDK, JPM, VICR
- Stocks Supported as Crude Oil Prices EaseThe S&P 500 Index ($SPX ) (SPY ) is up by +0.09% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.52%. December E-mini S&P…NasdaqALK, SAIA, UAL, MPC
- Stocks Mixed as Crude Oil Prices and Financial Stocks FallThe S&P 500 Index ($SPX ) (SPY ) is up by +0.01% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.43%. December E-mini S&P…NasdaqC, SNDK, JPM, VICR
- Veeva Expands Amgen Partnership With Global Vault CRM Rollout PlanVEEV expands its decade-long Amgen partnership with a global Vault CRM rollout, reinforcing enterprise adoption and commercial subscription growth.NasdaqAMGN, VEEV, GMED, VCYT
- Biotech ETFs to Buy as Cancer Drug Breakthroughs AccelerateBiotech ETFs offer diversified exposure to oncology innovation as cancer funding surges and the global oncology drug market expands.NasdaqAMGN, ILMN, MRNA, HALO
- The Zacks Analyst Blog Highlights AMD, Linde, Amgen and INNOVATEAMD's AI infrastructure demand is broadening as EPYC CPUs and Instinct accelerators gain traction, while Helios ramps and multigigawatt commitments boost visibility.NasdaqAMD, AMGN, LIN, VATE
- Top Research Reports for AMD, Linde & AmgenAMD, Linde and Amgen highlight AI demand, contracted growth and drug launches, while supply, margin and pipeline risks remain key factors.NasdaqAMD, AMGN, LIN, VATE
- Can Sotyktu's Long-Term PsA Data Boost Bristol Myers' Prospects?Bristol Myers' Sotyktu delivers durable PsA responses for two years, supporting its growth strategy as competition intensifies.NasdaqBMY, AMGN, TAK
- Worried About a Market Crash? This Dividend Stock Outperformed as the S&P 500 Sank in Both 2008 and 2022Key PointsAmgen has proven that it can manage market downturns fairly well.NasdaqAMGN, NVS
- Amgen Inc. (AMGN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking AlphaAMGN, MS
- Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?Key PointsAmgen maintains a massive global footprint and generated over $8.1 billion in free cash flow during its latest fiscal year.NasdaqAMGN, RVMD
- Amgen Inc. (AMGN) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha
- Amgen: Buy The Novartis-Driven Selloff (Rating Upgrade)Seeking AlphaAMGN, NVS
- Notable ETF Inflow Detected - DIA, AMGN, TRV, SHWLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Dow Jones Industrial Average ETF Trust (Symbol: DIA) where we…NasdaqDIA, AMGN, TRV, SHW
- Amgen: Why Rivals' Cholesterol Drug Failure Is Bad News For The Pharma (Rating Downgrade)Seeking Alpha
- Revolution Medicines Got Its Breakthrough—What Moves It Next?Revolution Medicines (NASDAQ: RVMD) just landed one of the biggest wins in oncology this year, and the stock barely blinked. On Aug. 26, the FDA approved RASONQUE (daraxonrasib), the first broad…NasdaqRVMD, LLY, AMGN, MRK
- Top Research Reports for Amgen, Thermo Fisher & PepsiAmgen, Thermo Fisher and PepsiCo headline today's research, with growth drivers, strategic moves and key risks in focus.NasdaqADI, SRE, AMGN, TMO
- Amgen: The Market Is Underestimating Its Next Growth PhaseSeeking Alpha
- Amgen: First $10 Billion Quarter, More Growth AheadSeeking Alpha
- Amgen Inc. (AMGN) Q2 2026 Earnings Call TranscriptSeeking Alpha
- Amgen Inc. 2026 Q2 - Results - Earnings Call PresentationSeeking Alpha